NCT02199145View on ClinicalTrials.gov

Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 17, 2015

Primary Completion Date

June 4, 2020

Study Completion Date

June 4, 2020

Conditions
Membranous Nephropathy
Interventions
PROCEDURE

Blood and urine analysis

creatinine, albumin, blood electrolytes, proteinuria / creatinine in sample 1 assay Ac anti-PLA2R1 on 3 ELISA (human, rabbit and mouse)

Trial Locations (3)

13354

AP-HM, Marseille

Unknown

CHU de Besançon, Besançon

06003

Nephrology Department, Nice University Hospital, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02199145 - Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy | Biotech Hunter | Biotech Hunter